Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Parecoxib for prevention of postoperative delirium in patients with hyperlipidemia
ChiCTR2300073880Phase 4Completed
- Sponsor
- Affiliated Hospital of Southwest Medical University
- Start
- Aug 2023
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of parecoxib in delirium (2 arms), sponsored by Affiliated Hospital of Southwest Medical University. Primary endpoint: delirium. Started Aug 2023; status: completed.
02
Drugs
parecoxib
03
Conditions
delirium
Beyond the preview
Go deeper on ChiCTR2300073880.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300073880.